ASHLEY FAUSNAUGH: Open Payments
NPI 1801339593 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 59 payments from 11 companies in 2025. Trend: 2023 $360 · 2024 $705 · 2025 $871
Food & beverage: $861Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $237 |
| ABBVIE INC. | 16 | $183 |
| Ardelyx, Inc. | 10 | $145 |
| Gilead Sciences, Inc. | 4 | $74 |
| QOL Medical, LLC | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Madrigal Pharmaceuticals | 2 | $39 |
| GENZYME CORPORATION | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Novo Nordisk Inc | 1 | $19 |
Products named: TREMFYA, IBSRELA, RINVOQ, SKYRIZI, MAVYRET, Sucraid, ENTYVIO, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
